Implications of using different cut-offs on symptom severity scales to define remission from depression
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
A fundamental question in the medical management of disease is how well treatment works. Although there are many ways of defining improvement, one endpoint of definite interest is the resolution or remission of the disorder. In short-term antidepressant treatment trials, remission is usually defined according to post-treatment scores on symptom severity measures, such as the Hamilton Rating Scale for Depression (HRSD) or the Montgomery-Asberg Depression Rating Scale (MADRS). However, there is uncertainty as to what cut-offs should be used on these measures to define remission. During the past 2 years, as part of the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, our laboratory has examined the question of how to define remission on the HRSD and MADRS. In the present report from the MIDAS project, we examined the impact of the cut-off score used to define remission on the percentage of depressed outpatients in ongoing treatment who are considered to be in remission. In addition, we examined the association between remission status and psychosocial impairment for different cut-off scores. Three hundred and three depressed psychiatric outpatients were rated on the MADRS, 17-item HRSD, and an index of DSM-IV remission status. Approximately one-third of patients completed a measure of psychosocial impairment. For both the HRSD and the MADRS, we examined four cut-off scores for remission. For each cut-off, we determined the percentage of patients who met the definition of remission, the percentage of patients who continued to meet DSM-IV criteria for major depressive disorder (MDD), and the percentage of patients without any self-reported impairment from depression. For both scales, the range of cut-off scores was associated with more than a two-fold difference in prevalence of remission. Based on higher thresholds to define remission, a small percentage of patients met criteria for MDD, whereas no patients scoring below the low thresholds had MDD. The threshold to define remission was associated with psychosocial impairment: higher cut-off scores were associated with lower rates of no impairment. The cut-offs used to define remission from depression considerably influence the percentage of patients considered to be in remission. Lower cut-off scores than those most commonly used to define remission appear to be more valid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 5×
“A score of 7 is the one recommended by Frank et al. (1991), and it is the most frequently used cut-off, and it corresponds to the mean+1 SD in healthy controls.”
BackgroundMethodInfluentialKeller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643
Residual symptoms after partial remission: an important outcome in depression
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995) · Psychological Medicine · doi:10.1017/s0033291700033146 · Cited by 791 · cited 2×
“continue to experience more psychosocial impairment and have a higher likelihood of recurrence of a full depressive syndrome (Faravelli et al., 1986; Simons et al., 1986; Thase et al., 1992; Paykel et al., 1995; Judd et al., 1998; Judd et al., 2000a).”
BackgroundJudd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00138-4 · Cited by 590
Residual symptoms in depressed patients who respond acutely to fluoxetine
Nierenberg, A. A., Keefe, B. R., Leslie, V. C., Alpert, J. E., Pava, J. A., Worthington, J. J., Rosenbaum, J. F., & Fava, M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0403 · Cited by 470
Judd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., Maser, J. D., Mueller, T., Solomon, D. A., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1501 · Cited by 458
Keller, M. B. (2003) · JAMA · doi:10.1001/jama.289.23.3152 · Cited by 388 · cited 1×
“As recently discussed by Keller (2003), in the field of depression, it is equally important to clearly identify the goals of treatment.”
Background(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1046 · Cited by 252 · cited 2×
“continue to experience more psychosocial impairment and have a higher likelihood of recurrence of a full depressive syndrome (Faravelli et al., 1986; Simons et al., 1986; Thase et al., 1992; Paykel et al., 1995; Judd et al., 1998; Judd et al., 2000a).”
BackgroundTaragano, F. E., Allegri, R., Vicario, A., Bagnatti, P., & Lyketsos, C. G. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.340 · Cited by 103 · cited 2×
“…following the publication of the recommendations of Frank et al. (1991), a consensus has emerged to define remission on the HRSD as a score of 7 or less, although alternative thresholds continue to be used (Berk et al., 1997; Schweizer et al., 2001; Taragano et al., 2001; Trivedi et al., 2001).”
BackgroundInfluential
Cited by
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707
Tohen, M., Frank, E., Bowden, C. L., Colom, F., Ghaemi, S. N., Yatham, L. N., Malhi, G. S., Calabrese, J. R., Nolen, W. A., Vieta, E., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00726.x · Cited by 513
Brunoni, A. R., Moffa, A. H., Fregni, F., Palm, U., Padberg, F., Blumberger, D. M., Daskalakis, Z. J., Bennabi, D., Haffen, E., Alonzo, A., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.164715 · Cited by 414
Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder
Matza, L. S., Morlock, R., Sexton, C., Malley, K., & Feltner, D. (2010) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.323 · Cited by 269
de Zwart, P. L., Jeronimus, B. F., & de Jonge, P. (2019) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000227 · Cited by 189
Metadata
- Authors
- Zimmerman, M., Posternak, M. A., & Chelminski, I.
- Venue
- International Clinical Psychopharmacology
- Published
- 2004-07
- Volume
- 19
- Issue
- 4
- Pages
- 215-220
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2015677071
- Cited by
- 61
- References
- 9
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications of using different cut-offs on symptom severity scales to define remission from depression. https://app.cochat.ai/papers/10.1097/01.yic.0000130232.57629.46
- The paper
- Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004). Implications of using different cut-offs on symptom severity scales to define remission from depression. International Clinical Psychopharmacology. https://doi.org/10.1097/01.yic.0000130232.57629.46
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.